Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04834869 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

COVID-19 Vaccines Safety Tracking (CoVaST)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 6, 2022 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2021 to Dec 31, 2025
    • Study completion date: Jan 31, 2022 to Dec 31, 2026
    v6
  2. Study arms: 10 to 11v5
  3. Study sites: 15 to 14v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 15
    • Eligibility criteria shortened, about 19 words
    v3
  5. Study description shortened, about 15 wordsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effect of each COVID-19 vaccine among healthcare workers (HCW), old adults over +65 (OA), and schoolteachers (ST); b) to evaluate the potential demographic and medical risk factors for side effects frequency and intensity; c) to evaluate the long-term consequences of COVID-19 vaccines. The secondary objectives include a) to evaluate the relative safety of COVID-19 vaccines compared to each other; b) to evaluate the impact of palliative drugs used by the recently vaccinated individuals on their short-term side effects resolution.
Trial Details
NCT Number NCT04834869
Lead Sponsor Masaryk University
Conditions
(from sponsor)		 Adverse Reaction to Vaccine, COVID19 Vaccine
Related terms COVID-19
Enrollment 30,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov